Trial Information
Inclusion Criteria:
- Age 18-70
- Hematological disease
- Treatment with high-dose chemotherapy followed by autologous stem cell
transplantation
- Understanding of written German
Exclusion Criteria:
- Cardiorespiratory, metabolical, osteoarticular or immunological diseases which can be
aggravated by exercise
- Pathological stress-ECG at admission
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care
Outcome Measure:
VO2max
Outcome Time Frame:
At recruitment and after 3 weeks
Safety Issue:
No
Principal Investigator
Fernando Dimeo, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Charite University, Berlin, Germany
Authority:
Germany: Ethics Commission
Study ID:
EA4/029/09
NCT ID:
NCT00883961
Start Date:
December 2009
Completion Date:
September 2011
Related Keywords:
- Hematological Disease
- High-dose chemotherapy
- Hematological neoplasties
- Fatigue
- Cancer
- Exercise
- Sport
- Hematologic neoplastic disorders
- Hematologic Diseases